Kala Bio Inc (KALA)
7.08
+0.16
(+2.31%)
USD |
NASDAQ |
May 08, 16:00
6.80
-0.28
(-3.95%)
After-Hours: 20:00
Kala Bio Shareholders Equity (Quarterly): 7.504M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.504M |
| September 30, 2023 | 11.22M |
| June 30, 2023 | 17.49M |
| March 31, 2023 | 23.46M |
| December 31, 2022 | 18.97M |
| September 30, 2022 | -0.968M |
| June 30, 2022 | -31.55M |
| March 31, 2022 | -5.284M |
| December 31, 2021 | 16.80M |
| September 30, 2021 | 61.47M |
| June 30, 2021 | 84.27M |
| March 31, 2021 | 109.79M |
| December 31, 2020 | 100.00M |
| September 30, 2020 | 106.03M |
| June 30, 2020 | 128.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 141.51M |
| December 31, 2019 | 29.69M |
| September 30, 2019 | 43.06M |
| June 30, 2019 | 61.07M |
| March 31, 2019 | 82.37M |
| December 31, 2018 | 104.98M |
| September 30, 2018 | 54.93M |
| June 30, 2018 | 68.09M |
| March 31, 2018 | 80.27M |
| December 31, 2017 | 89.68M |
| September 30, 2017 | 98.86M |
| June 30, 2017 | -107.42M |
| March 31, 2017 | 22.47M |
| December 31, 2016 | -87.76M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-31.55M
Minimum
Jun 2022
141.51M
Maximum
Mar 2020
48.60M
Average
29.69M
Median
Dec 2019
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 12.65M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Protalix BioTherapeutics Inc | 33.57M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 55.95M |
| Total Liabilities (Quarterly) | 48.44M |